These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 37398674)

  • 1. Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade.
    Tian W; Qin G; Jia M; Li W; Cai W; Wang H; Zhao Y; Bao X; Wei W; Zhang Y; Shao Q
    Front Immunol; 2023; 14():1198551. PubMed ID: 37398674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of T-cell exhaustion: Mechanisms and synergistic approaches.
    Hu Y; Zhang Y; Shi F; Yang R; Yan J; Han T; Guan L
    Int Immunopharmacol; 2024 Sep; 138():112571. PubMed ID: 38941674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell exhaustion in human cancers.
    Kang K; Lin X; Chen P; Liu H; Liu F; Xiong W; Li G; Yi M; Li X; Wang H; Xiang B
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189162. PubMed ID: 39089484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Zhang B; Liu J; Mo Y; Zhang K; Huang B; Shang D
    Front Immunol; 2024; 15():1476904. PubMed ID: 39372416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TOX-expressing terminally exhausted tumor-infiltrating CD8
    Han HS; Jeong S; Kim H; Kim HD; Kim AR; Kwon M; Park SH; Woo CG; Kim HK; Lee KH; Seo SP; Kang HW; Kim WT; Kim WJ; Yun SJ; Shin EC
    Cancer Lett; 2021 Feb; 499():137-147. PubMed ID: 33249194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle.
    Lin WP; Li H; Sun ZJ
    EBioMedicine; 2024 Jun; 104():105154. PubMed ID: 38749300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
    Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.
    McLane LM; Abdel-Hakeem MS; Wherry EJ
    Annu Rev Immunol; 2019 Apr; 37():457-495. PubMed ID: 30676822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming T Cell Exhaustion in Tumor Microenvironment via Immune Checkpoint Modulation with Nano-Delivery Systems for Enhanced Immunotherapy.
    Huang X; Zhang W
    Small Methods; 2024 Aug; 8(8):e2301326. PubMed ID: 38040834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Dolina JS; Van Braeckel-Budimir N; Thomas GD; Salek-Ardakani S
    Front Immunol; 2021; 12():715234. PubMed ID: 34354714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into T-cell exhaustion in liver cancer: from mechanism to therapy.
    Hao L; Li S; Hu X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12543-12560. PubMed ID: 37423958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Road Less Taken: Less Appreciated Pathways for Manipulating CD8
    Pichler AC; Cannons JL; Schwartzberg PL
    Front Immunol; 2022; 13():926714. PubMed ID: 35874734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitherapy and immune checkpoint blockade: using epigenetic reinvigoration of exhausted and dysfunctional T cells to reimburse immunotherapy response.
    McGoverne I; Dunn J; Batham J; Tu WJ; Chrisp J; Rao S
    BMC Immunol; 2020 Apr; 21(1):22. PubMed ID: 32316916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade.
    Budimir N; Thomas GD; Dolina JS; Salek-Ardakani S
    Cancer Immunol Res; 2022 Feb; 10(2):146-153. PubMed ID: 34937730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective control of transposable element expression during T cell exhaustion and anti-PD-1 treatment.
    Bonté PE; Metoikidou C; Heurtebise-Chretien S; Arribas YA; Sutra Del Galy A; Ye M; Niborski LL; Zueva E; Piaggio E; Seguin-Givelet A; Girard N; Alanio C; Burbage M; Goudot C; Amigorena S
    Sci Immunol; 2023 Oct; 8(88):eadf8838. PubMed ID: 37889984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling T-cell Exhaustion: Genetic Screening Meets In Vitro Modeling.
    Schmid D; Auf der Maur P; Trefny MP; Zippelius A
    Cancer Res; 2023 Dec; 83(23):3830-3832. PubMed ID: 37855668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer.
    Stromnes IM; Hulbert A; Rollins MR; Basom RS; Delrow J; Bonson P; Burrack AL; Hingorani SR; Greenberg PD
    J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35210305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer.
    Kim CG; Kim G; Kim KH; Park S; Shin S; Yeo D; Shim HS; Yoon HI; Park SY; Ha SJ; Kim HR
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34907028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition.
    Zhao M; Li L; Kiernan CH; Castro Eiro MD; Dammeijer F; van Meurs M; Brouwers-Haspels I; Wilmsen MEP; Grashof DGB; van de Werken HJG; Hendriks RW; Aerts JG; Mueller YM; Katsikis PD
    Sci Rep; 2023 Sep; 13(1):15678. PubMed ID: 37735204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.